Physician profile
Tracy L Ringo
NPI 1649231804
$2,060.07
in general payments reported to CMS, 2019-2025
21 companies · $578 in 2025
The $578 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $252 · 2021: $57.38 · 2022: $25.43 · 2023: $209 · 2024: $242 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $458.77 | 2019-2020 | |
| Pfizer INC. | $333.88 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $163.12 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $142.34 | 2019-2023 | Dupixent |
| Sun Pharmaceutical Industries INC. | $124.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $123.60 | 2019-2025 | Cabtreo, Jublia, Arazlo |
| Organon LLC | $112.79 | 2025 | Vtama |
| Almirall LLC | $108.19 | 2019 | |
| Lilly USA, LLC | $84.06 | 2024-2025 | Olumiant, Ebglyss |
| Leo Pharma INC. | $73.94 | 2019-2022 | |
| Botanix Sb INC | $54.39 | 2025 | Sofdra |
| Ucb, INC. | $45.03 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $35.91 | 2019-2023 | |
| Epi Health, LLC | $32.79 | 2019 | |
| Arcutis Biotherapeutics, INC. | $32.43 | 2025 | Zoryve |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $31.94 | 2023 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $28.43 | 2023-2025 | Sotyktu |
| Incyte Corporation | $20.48 | 2025 | Opzelura |
| Vyne Pharmaceuticals INC. | $20.42 | 2020 | |
| Abbvie INC. | $18.71 | 2023 | Skyrizi |
| Novum Pharma, LLC | $14.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Ringo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.